IDEXX Laboratories, Inc. Common Stock Earnings Dividend

IDEXX Laboratories, Inc. Common Stock’s revenue jumped 9.66% since last year same period to $1216.59Mn in the Q2 2026. On a quarterly growth basis, IDEXX Laboratories, Inc. Common Stock has generated 6.64% jump in its revenue since last 3-months.

IDEXX Laboratories, Inc. Common Stock’s net profit jumped 15.11% since last year same period to $338.41Mn in the Q2 2026. On a quarterly growth basis, IDEXX Laboratories, Inc. Common Stock has generated 21.54% jump in its net profits since last 3-months.

IDEXX Laboratories, Inc. Common Stock’s net profit margin jumped 4.97% since last year same period to 27.82% in the Q2 2026. On a quarterly growth basis, IDEXX Laboratories, Inc. Common Stock has generated 13.97% jump in its net profit margins since last 3-months.

IDEXX Laboratories, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 3.95 - a 15.84% jump from last quarter’s estimates.

IDEXX Laboratories, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 3.95.

IDEXX Laboratories, Inc. Common Stock’s earning per share (EPS) jumped 17.63% since last year same period to 4.27 in the Q2 2026. This indicates that the IDEXX Laboratories, Inc. Common Stock has generated 17.63% annual rate of jump in its earning per share (EPS) in the last 4 quarters.